These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio). Verma A; Abisheganaden J; Light RW Lung; 2016 Feb; 194(1):147-53. PubMed ID: 26678281 [TBL] [Abstract][Full Text] [Related]
3. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count). Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157 [No Abstract] [Full Text] [Related]
4. Detection of Pleural Fluid Biochemistry Changes in Two Consecutive Thoracenteses for Differentiating Malignant from Benign Effusions. Bielsa S; García-Zamalloa A; Monteagudo P; González-Sans D; Ascanio D; Esquerda A; Taboada-Gómez J; Porcel JM Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):320-326. PubMed ID: 29496288 [TBL] [Abstract][Full Text] [Related]
5. Pleural fluid findings as prognostic factors for malignant pleural mesothelioma. Gonlugur TE; Gonlugur U J Clin Lab Anal; 2008; 22(5):334-6. PubMed ID: 18803276 [TBL] [Abstract][Full Text] [Related]
6. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients. Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion. Shi XY; Yi FS; Wang Z; Qiao X; Zhai K Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116 [TBL] [Abstract][Full Text] [Related]
8. [Pleural effusions--experience of Pneumo-phtisiology Hospital Tudor Vladimirescu--I: Clinical study]. Olaru M; Pleşea IE; Mălăescu D; Olaru R Pneumologia; 2008; 57(3):138-46. PubMed ID: 18998326 [TBL] [Abstract][Full Text] [Related]
9. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis. Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications. Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937 [TBL] [Abstract][Full Text] [Related]
11. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters. Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381 [TBL] [Abstract][Full Text] [Related]
12. Cytologically proved malignant pleural effusions: distribution of transudates and exudates. Assi Z; Caruso JL; Herndon J; Patz EF Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310 [TBL] [Abstract][Full Text] [Related]
13. Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion. Verma A; Phua CK; Sim WY; Algoso RE; Tee KS; Lew SJ; Lim AY; Goh SK; Tai DY; Kor AC; Ho B; Abisheganaden J Medicine (Baltimore); 2016 Jun; 95(26):e3996. PubMed ID: 27368006 [TBL] [Abstract][Full Text] [Related]
14. Differentiating tuberculous from malignant pleural effusions: a scoring model. Porcel JM; Vives M Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453 [TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis between exudate and transudate in pleural effusion]. Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477 [TBL] [Abstract][Full Text] [Related]
16. Homocysteine: new tumor marker in pleural fluid. Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279 [TBL] [Abstract][Full Text] [Related]
17. Pleural and serum markers for diagnosis of malignant pleural effusion. Allama AM; Abou-Elela DH; Ibrahim IM Asian Cardiovasc Thorac Ann; 2020 Nov; 28(9):560-565. PubMed ID: 32741198 [TBL] [Abstract][Full Text] [Related]
18. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Rooper LM; Ali SZ; Olson MT Cancer Cytopathol; 2014 Sep; 122(9):657-65. PubMed ID: 25060164 [TBL] [Abstract][Full Text] [Related]
19. A decision tree for differentiating tuberculous from malignant pleural effusions. Porcel JM; Alemán C; Bielsa S; Sarrapio J; Fernández de Sevilla T; Esquerda A Respir Med; 2008 Aug; 102(8):1159-64. PubMed ID: 18573650 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance. Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]